Shaun Lee, a leader of Ezra Capital, has cultivated a particular investment framework predicated upon patient value creation. Their strategy generally comprises a rigorous screening process, targeting undervalued companies within various sectors. Lee and his group often employs a granular investigation method , emphasizing intrinsic assessment and